Sign in
Active, not recruitingPhase 4

Painful Inflammatory Carpometacarpal-1 osteoArthritis treated with intraarticular Steroids, Saline or an Occupational therapy intervention: the PICASSO trial

Key facts

Who runs it
Diakonhjemmet Sykehus AS
Where
Norway6 sites in 1 countryChoose a country to see its sites
Status
Active, not recruiting
Phase
Phase 4
People taking part
354 people, planned
Started
3 Nov 2023
Expected to end
1 Oct 2028
Type of study
Interventional
Record updated
26 June 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 25 criteriaShow less

Who can take part

  • Men and women between 40-85 years of age
  • Osteoarthritis in target CMC-1 joint confirmed by radiographs or ultrasound examination
  • Inflammation in target CMC-1 joint confirmed by ultrasound (grey scale synovitis grade 1-3)
  • Pain in target CMC-1 joint of at least 3 on a 0-10 Numeric rating scale (NRS) at rest or during activities at both pre-screening and screening
  • Patient is assessed as eligible for the proposed use of Kenacort-T

Who cannot take part

  • Patients vaccinated or immunized with live virus vaccines in the last 2 weeks
  • More than three previous IACS injections in the target CMC-1 joint
  • Use of oral, intramuscular, or intravenous steroids in the last 12 weeks
  • Previous surgery of the target CMC-1 joint
  • Planned hand surgery in the coming 24 weeks
  • Systemic inflammatory joint diseases (including but not limited to rheumatoid arthritis (RA), psoriatic arthritis or gout) or other conditions that can better explain the hand pain (such as thoracic outlet syndrome, carpal tunnel disease, diabetic cheiropathy, hand injury in previous six months, or palmar tenosynovitis/trigger finger)
  • Infection, skin disease or wounds at joint injection site
  • Serious comorbidities, cognitive dysfunction, substance/alcohol abuse or any other medical condition that makes adherence to the study protocol difficult
  • Severe or uncontrolled infections
  • Any condition that in the view of the investigator would suggest that the patient is unable to comply with the study protocol and procedures
  • Known hypersensitivity to Triamcinolone acetonide (Kenacort) or any of the excipients (sodium carboxymethylcellulose, sodium chloride, polysorbate, benzyl alcohol, sodium hydroxide or hydrochloric acid)
  • Use of thumb orthosis on most of the days or structured hand exercises in the last 12 weeks
  • Diagnosis of psoriasis
  • Use of digitalis glycosides
  • Included in another clinical study
  • Not being able to speak or understand Norwegian
  • Intraarticular injections in the target CMC-1 joint in the last 12 weeks
  • Known pregnancy or planned pregnancy in the next 6 months
  • Refuse to quit using oral or topical NSAIDs on the hands (such as ibuprofen, diclofenac, etoricoxib, naproxen) in the next 12 weeks
  • Diagnosis of fibromyalgia

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

To assess whether intraarticular corticosteroid (IACS) injections are superior to saline injections after 4 weeks, and compare the efficacy of IACS injections, saline injections and a multimodal occupational therapy intervention after 12 weeks in patients with painful inflammatory OA in the first carpometacarpal joint.

Data and sources

Registry record
Listed on the EU's official list of trials (CTIS).How to verify a trial in the registry
Record updated
26 June 2025